Mechanistically, IPI-549 treatment decreased AKTphosphorylation and HIF-1α levels; therefore, thePI3K/pAKT/HIF-1α signaling pathway is considered to play an essentialrole in AAA [85]. Here, HIF1A is linked to triple-A syndrome.